<p class="jove_content">This systematic review and meta-analysis pooled 12 lung-cancer models predicting checkpoint inhibitor pneumonitis. Validation C-statistics averaged 0.82, but a 0.51&#8211;0.95 prediction interval, predominantly unclear risk of bias with two high-risk studies, and scarce external validation preclude clinical deployment.</p>

machine-learning-radiomics-clinical-models-predicting-checkpoint

Machine Learning, Radiomics, and Clinical Models Predicting Checkpoint Inhibitor Pneumonitis in Lung Cancer: A Systematic Review and Meta-analysis

Checkpoint inhibitor pneumonitis (CIP) is a potentially fatal immune-related adverse event of immune checkpoint inhibitor (ICI) therapy in lung cancer, ...

Institution - The 988th Hospital of the Joint Logistics Support Force

Articles Published in JoVE